These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

447 related items for PubMed ID: 15194006

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Synthetic and naturally occurring COX-2 inhibitors suppress proliferation in a human oesophageal adenocarcinoma cell line (OE33) by inducing apoptosis and cell cycle arrest.
    Cheong E, Ivory K, Doleman J, Parker ML, Rhodes M, Johnson IT.
    Carcinogenesis; 2004 Oct; 25(10):1945-52. PubMed ID: 15155531
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Growth inhibition of breast epithelial cells by celecoxib is associated with upregulation of insulin-like growth factor binding protein-3 expression.
    Levitt RJ, Buckley J, Blouin MJ, Schaub B, Triche TJ, Pollak M.
    Biochem Biophys Res Commun; 2004 Apr 02; 316(2):421-8. PubMed ID: 15020235
    [Abstract] [Full Text] [Related]

  • 27. COX-1 and COX-2 inhibitors.
    Hawkey CJ.
    Best Pract Res Clin Gastroenterol; 2001 Oct 02; 15(5):801-20. PubMed ID: 11566042
    [Abstract] [Full Text] [Related]

  • 28. [Influence of selective cyclooxygenase-2 inhibitor on proliferation of human gastric cancer cells].
    Li JY, Yu JP, Luo HS, Yu BP, Tian G, Mei Q, Huang JA.
    Ai Zheng; 2002 Jun 02; 21(6):625-9. PubMed ID: 12452063
    [Abstract] [Full Text] [Related]

  • 29. Ulcerogenic influence of selective cyclooxygenase-2 inhibitors in the rat stomach with adjuvant-induced arthritis.
    Kato S, Ogawa Y, Kanatsu K, Okayama M, Watanabe T, Arakawa T, Takeuchi K.
    J Pharmacol Exp Ther; 2002 Nov 02; 303(2):503-9. PubMed ID: 12388629
    [Abstract] [Full Text] [Related]

  • 30. Antiproliferative and apoptotic effects of rofecoxib on esophageal cancer in vitro(1).
    Vona-Davis L, Riggs DR, Jackson BJ, McFadden DW.
    J Surg Res; 2004 Jun 15; 119(2):143-8. PubMed ID: 15145696
    [Abstract] [Full Text] [Related]

  • 31. A novel celecoxib derivative potently induces apoptosis of human synovial fibroblasts.
    Kusunoki N, Ito T, Sakurai N, Suguro T, Handa H, Kawai S.
    J Pharmacol Exp Ther; 2005 Aug 15; 314(2):796-803. PubMed ID: 15870389
    [Abstract] [Full Text] [Related]

  • 32. Longer use of COX-2-specific inhibitors compared to nonspecific nonsteroidal antiinflammatory drugs: a longitudinal study of 3639 patients in community practice.
    Wolfe F, Michaud K, Burke TA, Zhao SZ.
    J Rheumatol; 2004 Feb 15; 31(2):355-8. PubMed ID: 14760808
    [Abstract] [Full Text] [Related]

  • 33. Progestogens stimulate prostacyclin production by human endothelial cells.
    Hermenegildo C, Oviedo PJ, García-Martínez MC, García-Pérez MA, Tarín JJ, Cano A.
    Hum Reprod; 2005 Jun 15; 20(6):1554-61. PubMed ID: 15734756
    [Abstract] [Full Text] [Related]

  • 34. Valdecoxib: assessment of cyclooxygenase-2 potency and selectivity.
    Gierse JK, Zhang Y, Hood WF, Walker MC, Trigg JS, Maziasz TJ, Koboldt CM, Muhammad JL, Zweifel BS, Masferrer JL, Isakson PC, Seibert K.
    J Pharmacol Exp Ther; 2005 Mar 15; 312(3):1206-12. PubMed ID: 15494548
    [Abstract] [Full Text] [Related]

  • 35. The cyclooxygenase 2-selective inhibitor NS398 inhibits proliferation of oral carcinoma cell lines by mechanisms dependent and independent of reduced prostaglandin E2 synthesis.
    Minter HA, Eveson JW, Huntley S, Elder DJ, Hague A.
    Clin Cancer Res; 2003 May 15; 9(5):1885-97. PubMed ID: 12738747
    [Abstract] [Full Text] [Related]

  • 36. Gene modulation by Cox-1 and Cox-2 specific inhibitors in human colorectal carcinoma cancer cells.
    Bottone FG, Martinez JM, Alston-Mills B, Eling TE.
    Carcinogenesis; 2004 Mar 15; 25(3):349-57. PubMed ID: 14633654
    [Abstract] [Full Text] [Related]

  • 37. Cardiovascular effects of selective cyclooxygenase-2 inhibitors.
    Krum H, Liew D, Aw J, Haas S.
    Expert Rev Cardiovasc Ther; 2004 Mar 15; 2(2):265-70. PubMed ID: 15151474
    [Abstract] [Full Text] [Related]

  • 38. Celecoxib: a potent cyclooxygenase-2 inhibitor in cancer prevention.
    Kismet K, Akay MT, Abbasoglu O, Ercan A.
    Cancer Detect Prev; 2004 Mar 15; 28(2):127-42. PubMed ID: 15068837
    [Abstract] [Full Text] [Related]

  • 39. Insulin-like growth factor-I antagonizes the antiproliferative effects of cyclooxygenase-2 inhibitors on BxPC-3 pancreatic cancer cells.
    Levitt RJ, Pollak M.
    Cancer Res; 2002 Dec 15; 62(24):7372-6. PubMed ID: 12499282
    [Abstract] [Full Text] [Related]

  • 40. Radiosensitivity enhancement by celecoxib, a cyclooxygenase (COX)-2 selective inhibitor, via COX-2-dependent cell cycle regulation on human cancer cells expressing differential COX-2 levels.
    Shin YK, Park JS, Kim HS, Jun HJ, Kim GE, Suh CO, Yun YS, Pyo H.
    Cancer Res; 2005 Oct 15; 65(20):9501-9. PubMed ID: 16230415
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.